Atrium Therapeutics Inc (RNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 09-2019 | 06-2019 | 09-2014 | 06-2014 | |
| Sales | 1,358 | 650 | 224 | 0 | 0 |
| Gross Profit | 1,358 | 650 | 224 | 0 | 0 |
| Operating Expenses | 1,964 | 757 | 1,596 | 11,130 | 7,590 |
| Operating Income | -606 | -107 | -1,372 | -11,130 | -7,590 |
| Interest Expense | 78 | 1,462 | 1,215 | 0 | 0 |
| Other Income | -5,401 | -5,099 | -2,529 | 0 | 0 |
| Pre-tax Income | -6,085 | -6,668 | -5,116 | -11,130 | -7,590 |
| Net Income Continuous | -6,085 | -6,668 | -5,116 | -11,130 | -7,590 |
| Net Income | $-6,085 | $-6,668 | $-5,116 | $-11,130 | $-7,590 |
| EBITDA(a) | $-606 | $-107 | $-1,372 | $-10,690 | $-7,180 |